1. Home
  2. PHVS vs LPG Comparison

PHVS vs LPG Comparison

Compare PHVS & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • LPG
  • Stock Information
  • Founded
  • PHVS 2015
  • LPG 2013
  • Country
  • PHVS Switzerland
  • LPG United States
  • Employees
  • PHVS N/A
  • LPG N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • LPG Marine Transportation
  • Sector
  • PHVS Health Care
  • LPG Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • LPG Nasdaq
  • Market Cap
  • PHVS 1.3B
  • LPG 1.4B
  • IPO Year
  • PHVS 2021
  • LPG 2014
  • Fundamental
  • Price
  • PHVS $21.65
  • LPG $31.96
  • Analyst Decision
  • PHVS Buy
  • LPG Strong Buy
  • Analyst Count
  • PHVS 6
  • LPG 1
  • Target Price
  • PHVS $36.67
  • LPG $35.00
  • AVG Volume (30 Days)
  • PHVS 118.6K
  • LPG 561.3K
  • Earning Date
  • PHVS 08-12-2025
  • LPG 10-30-2025
  • Dividend Yield
  • PHVS N/A
  • LPG 10.01%
  • EPS Growth
  • PHVS N/A
  • LPG N/A
  • EPS
  • PHVS N/A
  • LPG 1.15
  • Revenue
  • PHVS N/A
  • LPG $320,692,009.00
  • Revenue This Year
  • PHVS N/A
  • LPG $24.57
  • Revenue Next Year
  • PHVS N/A
  • LPG N/A
  • P/E Ratio
  • PHVS N/A
  • LPG $27.77
  • Revenue Growth
  • PHVS N/A
  • LPG N/A
  • 52 Week Low
  • PHVS $11.51
  • LPG $16.66
  • 52 Week High
  • PHVS $26.33
  • LPG $39.14
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 47.92
  • LPG 64.32
  • Support Level
  • PHVS $21.56
  • LPG $31.37
  • Resistance Level
  • PHVS $24.52
  • LPG $32.28
  • Average True Range (ATR)
  • PHVS 1.32
  • LPG 0.63
  • MACD
  • PHVS -0.07
  • LPG 0.02
  • Stochastic Oscillator
  • PHVS 28.04
  • LPG 88.59

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About LPG Dorian LPG Ltd.

Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.

Share on Social Networks: